InsiderSignal.AI

InsiderSignal.ai

TVTX - Travere Therapeutics, Inc.

Insider Sale by Calvin Sandra (SVP, Chief Accounting Officer)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

3 days ago, Calvin Sandra, serving as SVP, Chief Accounting Officer at Travere Therapeutics, Inc. (TVTX), sold 21,977 shares at $41.07 per share, for a total transaction value of $902,595.00. Following this transaction, Calvin Sandra now holds 42,353 shares of TVTX.

This sale represents a 34.00% decrease in Calvin Sandra's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, April 14, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, April 16, 2026, 2 days after the trade was made.

Travere Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Calvin Sandra

SVP, Chief Accounting Officer

Sandra Calvin is the Senior Vice President and Chief Accounting Officer at Travere Therapeutics, Inc. (NASDAQ: TVTX), a biopharmaceutical company focused on developing therapies for rare kidney and genetic disorders.[[1]](https://uk.investing.com/news/insider-trading-news/travere-therapeutics-tvtx-svp-calvin-sells-296k-in-stock-93CH-4432810)[[2]](https://www.gurufocus.com/news/4072628/insider-sell-sandra-calvin-sells-shares-of-travere-therapeutics-inc-tvtx)[[5]](https://www.marketbeat.com/instant-alerts/insider-selling-travere-therapeutics-nasdaqtvtx-cao-sells-7402-shares-of-stock-2025-12-29/) In this role, she oversees the company's accounting functions and has been actively involved in insider trading activities, including multiple share sales in late 2025: 2,910 shares on December 15 at $36 each, 7,402 shares on December 24 at $40 each for $296,080, and 67,115 shares on November 4 at $36 for approximately $2.42 million, often under a pre-arranged 10b5-1 trading plan.[[1]](https://uk.investing.com/news/insider-trading-news/travere-therapeutics-tvtx-svp-calvin-sells-296k-in-stock-93CH-4432810)[[2]](https://www.gurufocus.com/news/4072628/insider-sell-sandra-calvin-sells-shares-of-travere-therapeutics-inc-tvtx)[[3]](https://www.ainvest.com/news/travere-therapeutics-svp-calvin-sandra-sells-2910-shares-36-dec-15-2025-2512/)[[5]](https://www.marketbeat.com/instant-alerts/insider-selling-travere-therapeutics-nasdaqtvtx-cao-sells-7402-shares-of-stock-2025-12-29/) Following these transactions, she retained direct ownership of 38,233 shares as of December 24, 2025.[[1]](https://uk.investing.com/news/insider-trading-news/travere-therapeutics-tvtx-svp-calvin-sells-296k-in-stock-93CH-4432810)[[5]](https://www.marketbeat.com/instant-alerts/insider-selling-travere-therapeutics-nasdaqtvtx-cao-sells-7402-shares-of-stock-2025-12-29/) Calvin's tenure at Travere includes a history of insider sales dating back to at least 2022, with over 143,542 shares sold in the past year and no purchases reported.[[2]](https://www.gurufocus.com/news/4072628/insider-sell-sandra-calvin-sells-shares-of-travere-therapeutics-inc-tvtx)[[6]](https://fintel.io/n/calvin-sandra) She has also received option awards, such as 39,000 options on January 31, 2025.[[8]](https://www.secform4.com/insider-trading/1438533.htm) While specific details on her prior career experience and education are not available in the provided sources, her senior executive position highlights her expertise in financial accounting within the biopharmaceutical sector.[[9]](https://www.streetinsider.com/SEC+Filings/Form+4+Travere+Therapeutics,+For:+Dec+24+Filed+by:+Calvin+Sandra/25787386.html)

View full insider profile →

Trade Price

$41.07

Quantity

21,977

Total Value

$902,595.00

Shares Owned

42,353

Trade Date

Tuesday, April 14, 2026

3 days ago

SEC Filing Date

Thursday, April 16, 2026

Filed 2 days after trade

HEALTHCAREBIOTECHNOLOGY

About Travere Therapeutics, Inc.

Company Overview

No company information available
View news mentioning TVTX

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/5693654

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime